Directorate Change

Scapa Group Ltd (AIM: SCPA), a diversified Healthcare and Industrial company focused on bringing best-in-class innovation, design and manufacturing solutions to its customers, announces that having served as Chairman of the Company for over three years, Larry Pentz has decided not to offer himself for re-election at the 2020 Annual General Meeting (AGM). The Board has approved the appointment of Chris Brinsmead CBE as Larry’s successor. Chris’s appointment as Non-Executive Chairman will be effective from 7 August 2020 and he will offer himself for election at the AGM that same day. It has been agreed that Chris will commence his induction programme ahead of his appointment.

Chris has worked in the global healthcare sector for over forty years and has held a number of senior executive leadership positions. Chris is currently Chairman of Collagen Solutions plc and Proveca Ltd. He was previously Chairman of Consort Medical plc and the Senior Independent Director of UDG Healthcare plc. Chris was also formerly Chairman of AstraZeneca Pharmaceuticals UK, President of AstraZeneca UK and Ireland and President of the Association of the British Pharmaceutical Industry (ABPI). He has also held board positions at the Wesleyan Assurance Society, Domino Printing Sciences plc, Cambian Group plc and Kinapse Ltd. Chris is a Member of Council at Imperial College and was previously an advisor and champion of Life Sciences to the UK Government. Chris holds a BSc in Civil Engineering from Nottingham University and an MSc in Business Science from Manchester Business School.

Commenting on the changes, Heejae Chae, Chief Executive Officer, said:

"On behalf of the Board, I would like to express our thanks to Larry for his service, leadership and guidance over the past three years. Larry has chaired Scapa through a period of transition, witnessing the growth of our healthcare business and departs with our best wishes for the future."

"We are delighted to welcome Chris to Scapa. He is an established senior board member with a wealth of healthcare experience and significant international, operational and strategic expertise."

Larry Pentz added:

"I have enjoyed being part of the transformative journey of Scapa in which the Company has strengthened its market position, expanded, enhanced and optimised its business offering and built a strong platform for growth."

Commenting on his appointed, Chris Brinsmead, said:

"I look forward to joining the Board of Scapa and building on the Company's strong market position as a trusted partner to capitalise on the outlook and opportunities for the Healthcare and Industrial business divisions."

The Company makes the following disclosures in relation to Chris Brinsmead’s appointment in accordance with paragraph (g) of Schedule Two of the AIM Rules for Companies:

In addition to the appointment to the Board, Christopher David Brinsmead, aged 61, holds or has held the following directorships and partnerships in the past five years:

Current directorships/partnerships Previous directorships/partnerships held in the last 5 years
CDB (Meadowside) Limited Kinapse Limited
Proveca Limited Bamburgh Capital Limited
Collagen Solutions PLC Cambian Group Limited
Datapharm Communications Limited
Consort Medical Plc
UDG Healthcare Plc
Wesleyan Assurance Society

Chris Brinsmead is currently interested in a total of 20,000 ordinary shares of 5p each in the Company.

For further information:
Scapa Group Ltd Heejae Chae – Group Chief Executive
Oskar Zahn – Chief Financial Officer 
Tel: 0161 301 7430

Numis Securities Limited (Nominated Adviser/Joint Broker) 
Mark Lander, Freddie Barnfield 
Tel: 020 7260 1000

Berenberg (Joint Broker)
Chris Bowman, Toby Flaux 
Tel: 020 3207 7800

FTI Consulting (Media Relations) 
Simon Conway, Victoria Foster Mitchell 
Tel: 020 3727 1000

About Scapa Group Ltd 
Scapa Group Ltd is a diversified Healthcare and Industrial company focused on bringing best-in-class innovation, design and manufacturing solutions to its customers.

Scapa Healthcare is the trusted strategic partner of choice for the world’s leading companies in Advanced Wound Care, Consumer Wellness and Medical Device Fixation. We partner with the top global MedTech companies to develop and manufacture innovative skin friendly medical device fixation and topical solutions, from inception through to market delivery, from our state-of-the-art facilities. 
For further information, please visit

Scapa Industrial is a global supplier of bonding solutions and manufacturer of adhesive-based products which offer meaningful value in industrial applications due to their lightweight, easy-to-apply properties. We are recognised for our unparalleled range of products, including adhesive tapes, films and foams, and we can engineer custom designs for even the most unique applications.
For further information, please visit